+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review

Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bio-Rad Laboratories Inc (Bio-Rad) manufactures and distributes life science research and clinical diagnostics products. The company's product portfolio includes antibodies, autoimmune testing kits, blood typing and antibody detection systems, cell isolation and analysis tools, and digital PCR, among others. The company serves to various markets including life science research, healthcare, analytical chemistry, and other markets. Bio-Rad’s products find applications in bioprocess analytics, cell research, gene expression analysis, immunology, and mutation detection, among others. It markets products through a direct sales force and a network of distributors, agents, brokers, and resellers worldwide. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad Laboratories Inc is headquartered in Hercules, California, the US.

Bio-Rad Laboratories Inc Key Recent Developments

  • May 01, 2024: Seven Corporate Buyers Enter Into Aggregation Deal To Purchase 180 MW of Solar Energy Through the Net Zero Consortium for Buyers
  • May 01, 2024: Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
  • Apr 26, 2024: Bio-Rad Announces Life Science Group Management Changes
  • Apr 11, 2024: Bio-Rad’s Chief Operating Officer Andrew Last to Retire

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Bio-Rad Laboratories Inc - Key Facts
  • Bio-Rad Laboratories Inc - Key Employees
  • Bio-Rad Laboratories Inc - Key Employee Biographies
  • Bio-Rad Laboratories Inc - Major Products and Services
  • Bio-Rad Laboratories Inc - History
  • Bio-Rad Laboratories Inc - Company Statement
  • Bio-Rad Laboratories Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Bio-Rad Laboratories Inc - Business Description
  • Business Segment: Clinical Diagnostics
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Life Science
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Other Operations
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other
  • Target Markets
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Bio-Rad Laboratories Inc - Corporate Strategy
  • Bio-Rad Laboratories Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Bio-Rad Laboratories Inc - Strengths
  • Bio-Rad Laboratories Inc - Weaknesses
  • Bio-Rad Laboratories Inc - Opportunities
  • Bio-Rad Laboratories Inc - Threats
  • Bio-Rad Laboratories Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Bio-Rad Laboratories Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 01, 2024: Seven Corporate Buyers Enter Into Aggregation Deal To Purchase 180 MW of Solar Energy Through the Net Zero Consortium for Buyers
  • May 01, 2024: Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
  • Apr 26, 2024: Bio-Rad Announces Life Science Group Management Changes
  • Apr 11, 2024: Bio-Rad’s Chief Operating Officer Andrew Last to Retire
  • Apr 01, 2024: Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
  • Mar 26, 2024: Bio-Rad Launches Celselect Slides Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
  • Mar 20, 2024: Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
  • Feb 22, 2024: Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
  • Jan 02, 2024: Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
  • Oct 26, 2023: Bio-Rad Reports Third-Quarter 2023 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Bio-Rad Laboratories Inc, Key Facts
  • Bio-Rad Laboratories Inc, Key Employees
  • Bio-Rad Laboratories Inc, Key Employee Biographies
  • Bio-Rad Laboratories Inc, Major Products and Services
  • Bio-Rad Laboratories Inc, History
  • Bio-Rad Laboratories Inc, Subsidiaries
  • Bio-Rad Laboratories Inc, Key Competitors
  • Bio-Rad Laboratories Inc, Ratios based on current share price
  • Bio-Rad Laboratories Inc, Annual Ratios
  • Bio-Rad Laboratories Inc, Annual Ratios (Cont...1)
  • Bio-Rad Laboratories Inc, Annual Ratios (Cont...2)
  • Bio-Rad Laboratories Inc, Interim Ratios
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Bio-Rad Laboratories Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Bio-Rad Laboratories Inc, Performance Chart (2019 - 2023)
  • Bio-Rad Laboratories Inc, Ratio Charts
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthineers AG
  • Becton Dickinson and Co
  • Tosoh Corp
  • F. Hoffmann-La Roche Ltd
  • DiaSorin SpA
  • bioMerieux SA
  • Thermo Fisher Scientific Inc
  • Danaher Corp
  • Abbott Laboratories
  • Ortho Clinical Diagnostics Holdings Plc
  • Immucor Inc